Subtopic Deep Dive
Somatic Mutations in Autoinflammatory Rheumatic Diseases
Research Guide
What is Somatic Mutations in Autoinflammatory Rheumatic Diseases?
Somatic mutations in UBA1 and related genes drive VEXAS syndrome, an adult-onset autoinflammatory condition featuring polychondritis, vasculitis, and hematologic abnormalities in autoinflammatory rheumatic diseases.
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome arises from somatic UBA1 mutations in myeloid lineages, causing refractory inflammation and cytopenias. Deep sequencing identifies variants at methionine 41, distinguishing it from idiopathic relapsing polychondritis (Khitri et al., 2022; 82 citations). Over 20 papers since 2021 document its spectrum, including hematologic malignancies (Obiorah et al., 2021; 221 citations).
Why It Matters
VEXAS reclassifies polychondritis-like syndromes as somatic-driven autoinflammation, guiding targeted therapies like HSCT (Diarra et al., 2021; 137 citations). It explains treatment resistance in older males with otitis media and chondritis, enabling precision diagnostics via sequencing (Poulter et al., 2021; 221 citations). Beck et al. (2022; 116 citations) link UBA1 defects to inflammasome dysregulation, impacting rheumatic disease classification and HSCT outcomes in refractory cases.
Key Research Challenges
Detecting Low-VAF Mutations
Somatic UBA1 variants often have low variant allele frequencies in peripheral blood, complicating detection without deep sequencing. Poulter et al. (2021) identified novel M41 changes in UK patients using targeted panels. Gutierrez-Rodrigues et al. (2023; 98 citations) highlight clonal hematopoiesis confounding VAF interpretation in MDS-overlapping VEXAS.
Distinguishing Idiopathic RP
VEXAS mimics idiopathic relapsing polychondritis but shows worse outcomes and UBA1 mutations. Khitri et al. (2022; 82 citations) compared 95 French patients, finding VEXAS linked to higher mortality. Muratore et al. (2021; 89 citations) used phenotype-first screening in vasculitis cohorts to identify Italian cases.
Therapeutic Response Prediction
Inflammation resists glucocorticoids, with HSCT as the only cure in select cases. Diarra et al. (2021; 137 citations) reported success in two centers but variable engraftment. Al-Hakim and Savic (2022; 81 citations) note emerging variants and UBA1-negative mimics lacking clear therapies.
Essential Papers
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in <i>UBA1</i>
Ifeyinwa E. Obiorah, Bhavisha A. Patel, Emma M. Groarke et al. · 2021 · Blood Advances · 221 citations
Abstract Somatic mutations in UBA1 involving hematopoietic stem and myeloid cells have been reported in patients with the newly defined VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somat...
Novel somatic mutations in UBA1 as a cause of VEXAS syndrome
James A. Poulter, Jason C. Collins, Catherine Cargo et al. · 2021 · Blood · 221 citations
Poulter and colleagues describe a series from the United Kingdom of 10 male patients with VEXAS syndrome, including 2 with novel genetic changes affecting methionine 41 of E1.
Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience
Ava Diarra, Nicolas Duployez, Élise Fournier et al. · 2021 · Blood Advances · 137 citations
Abstract The recently described vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is caused by somatic mutations in UBA1. Patients with VEXAS syndrome display late-onset aut...
Disorders of ubiquitylation: unchained inflammation
David B. Beck, Achim Werner, Daniel L. Kastner et al. · 2022 · Nature Reviews Rheumatology · 116 citations
Spectrum of clonal hematopoiesis in VEXAS syndrome
Fernanda Gutierrez‐Rodrigues, Yael Kusne, Jenna Fernandez et al. · 2023 · Blood · 98 citations
VEXAS is caused by somatic mutations in UBA1 (UBA1mut) and characterized by heterogenous systemic auto-inflammation and progressive hematologic manifestations, meeting criteria for myelodysplastic ...
Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome
Frederik Staels, Albrecht Betrains, Feng Jung Sherida H. Woei-A-Jin et al. · 2021 · Frontiers in Immunology · 97 citations
Recently, a novel disorder coined VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome was identified in patients with adult-onset inflammatory syndromes, often accompanied by ...
<scp>VEXAS</scp> Syndrome: A Case Series From a <scp>Single‐Center</scp> Cohort of Italian Patients With Vasculitis
Francesco Muratore, Chiara Marvisi, Paola Castrignanò et al. · 2021 · Arthritis & Rheumatology · 89 citations
Objective To identify patients with VEXAS syndrome (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome) from a single‐center cohort of Italian patients with vasculitis, using a clini...
Reading Guide
Foundational Papers
Start with Obiorah et al. (2021; Blood Advances, 221 citations) for VEXAS hematology overview and Poulter et al. (2021; Blood, 221 citations) for novel mutations, establishing somatic UBA1 as causal.
Recent Advances
Study Gutierrez-Rodrigues et al. (2023; Blood, 98 citations) for clonal hematopoiesis spectrum and Khitri et al. (2022; RMD Open, 82 citations) for RP differentiation.
Core Methods
Deep sequencing for low-VAF detection (Poulter et al., 2021); HSCT for cure (Diarra et al., 2021); phenotype screening in vasculitis cohorts (Muratore et al., 2021).
How PapersFlow Helps You Research Somatic Mutations in Autoinflammatory Rheumatic Diseases
Discover & Search
Research Agent uses searchPapers and exaSearch to query 'UBA1 somatic mutations VEXAS polychondritis', retrieving Obiorah et al. (2021; Blood Advances) as top hit with 221 citations. citationGraph maps VEXAS clusters from Poulter et al. (2021) to Khitri et al. (2022), while findSimilarPapers uncovers Gutierrez-Rodrigues et al. (2023) on clonal hematopoiesis.
Analyze & Verify
Analysis Agent applies readPaperContent to extract mutation spectra from Poulter et al. (2021), then verifyResponse (CoVe) cross-checks VAF data against Obiorah et al. (2021). runPythonAnalysis processes mutation frequencies with pandas for statistical outliers, graded via GRADE for evidence strength in HSCT efficacy (Diarra et al., 2021).
Synthesize & Write
Synthesis Agent detects gaps in UBA1-negative polychondritis via contradiction flagging across Khitri et al. (2022) and Muratore et al. (2021). Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing 10+ VEXAS papers, with latexCompile generating figures and exportMermaid for mutation-inflammation pathway diagrams.
Use Cases
"Analyze UBA1 mutation VAF distributions across VEXAS patient cohorts"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of VAF from Obiorah et al. 2021 and Poulter et al. 2021) → matplotlib plots of clonal expansion stats.
"Write LaTeX review comparing VEXAS vs idiopathic relapsing polychondritis"
Synthesis Agent → gap detection → Writing Agent → latexEditText (structure sections) → latexSyncCitations (Khitri et al. 2022, Muratore et al. 2021) → latexCompile → PDF with embedded tables.
"Find code for UBA1 variant calling in VEXAS deep sequencing"
Research Agent → paperExtractUrls (from Poulter et al. 2021) → paperFindGithubRepo → githubRepoInspect → curated scripts for low-VAF somatic mutation detection.
Automated Workflows
Deep Research workflow scans 50+ VEXAS papers via searchPapers → citationGraph, producing structured reports on mutation-phenotype links (Obiorah et al., 2021). DeepScan's 7-step chain verifies HSCT outcomes with CoVe checkpoints across Diarra et al. (2021) and Gutierrez-Rodrigues et al. (2023). Theorizer generates hypotheses on UBA1-inflammasome pathways from Beck et al. (2022).
Frequently Asked Questions
What defines somatic mutations in autoinflammatory rheumatic diseases?
Somatic UBA1 mutations at M41 cause VEXAS syndrome, featuring polychondritis, vasculitis, and MDS-like hematology in older males (Obiorah et al., 2021; Poulter et al., 2021).
What methods detect these mutations?
Deep targeted sequencing of hematopoietic DNA identifies low-VAF UBA1 variants; Poulter et al. (2021) used panels on UK cohorts, Gutierrez-Rodrigues et al. (2023) integrated clonal hematopoiesis analysis.
What are key papers on VEXAS?
Obiorah et al. (2021; 221 citations) detail hematologic manifestations; Khitri et al. (2022; 82 citations) compare to idiopathic RP; Diarra et al. (2021; 137 citations) report HSCT success.
What open problems remain?
UBA1-negative VEXAS-like cases lack etiology (Al-Hakim and Savic, 2022); female cases are rare (Stubbins et al., 2021); optimal HSCT timing needs trials.
Research Otitis Media and Relapsing Polychondritis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Somatic Mutations in Autoinflammatory Rheumatic Diseases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers